v3.25.2
Segmentation (Tables)
 12 Months Ended
Dec. 31, 2024
Segmentation [Abstract]  
Schedule of Company’s Segment Results

The following table presents the Company’s segment results for the years ended December 31, 2024 and 2023:

 

   For the years ended 
   December 31, 
   2024   2023 
Sales, net  $141,760   $9,072,130 
Cost of goods sold   83,290    466,802 
Segment Gross profit   58,470    8,605,328 
           
Operating Expenses:          
Product development   1,373,351    693,448 
Sales and marketing   811,537    215,332 
General and administrative (A)   19,171,965    17,238,184 
Transaction costs including those incurred with contingent Earn-out Share Liability   55,038,544    
-
 
Depreciation and amortization   273,772    818,203 
Impairment on investment   216,278      
Stock-based compensation   6,699,081      
Inventory impairment   551,492      
           
Other income, net   (21,390)   59,982 
UK R&D tax credit   (1,251,243)   
-
 
Loss on initial issuance of convertible note   1,770,933    
-
 
Change in fair value of convertible note option liability   (840,933)   
-
 
Change in fair value of warrant liabilities   (200,124)   
-
 
Change in fair value of Earn-out Share Liability   (38,040,000)   
-
 
Other expense   244,732    (21,857)
Interest income   
-
    1,942 
Interest expense   1,808,243    (5,318,817)
Segment and Consolidated Net loss  $(47,547,768)  $(15,638,589)
Schedule of Net of Depreciation, Amortization Share-Based Compensation, Provisions and Impairments

Notes: (A)-net of depreciation, amortization share-based compensation, provisions and impairments.

 

   As of and
For Year Ended
December 31		 
Total Consolidated Assets  $21,093,895   $20,837,306 
Capital Expenditures  $265,445   $155,054